
Neuland Laboratories shares rose 10.2% to a record Rs 21,999 on the NSE on Thursday after the company reported its June quarter results and approved a capacity expansion in Telangana. The stock…
Neuland Laboratories shares rose 10.2% to a record Rs 21,999 on the NSE on Thursday after the company reported its June quarter results and approved a capacity expansion in Telangana. The stock had closed at Rs 19,956.
The company reported standalone profit after tax of Rs 147.36 crore for Q1FY27, up from Rs 13.71 crore a year earlier, though below Rs 212.52 crore in the March 2026 quarter. Its board approved adding 18 kilolitres of capacity at Unit 1 in Bonthapally, Sangareddy district, at a cost of Rs 39.8 crore. CEO Saharsh Davuluri said the CMS and GDS businesses performed well and that commercial products contributed most revenue.
The easy story is that one strong quarter and a record share price prove Neuland’s expansion will pay off. That is premature. Profit growth was sharp year on year, but the March quarter was higher, and the new capacity still needs to be built and used. Investors should watch whether quarterly profit stays above Rs 147 crore while the 18-kilolitre addition translates into revenue, not just plans.
Source: thehindubusinessline.com
This story was synthesised by AI from the source linked above.